Re: Herr et al.: BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4).

Overview

authors

Morales, Alvaro

Steinberg, Gary

Herr, Harry Wallace

publication date

August 1, 2015

published in

Urologic oncology Journal

Research

keywords

BCG Vaccine
Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

84937409439

Digital Object Identifier (DOI)

10.1016/j.urolonc.2015.05.010

PubMed ID

26182846

Additional Document Info

volume

33

issue

8